HSV-1 therapy of primary tumors reduces the number of metastases in an immune-competent model of metastatic breast cancer (Q79124523)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529826%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

HSV-1 therapy of primary tumors reduces the number of metastases in an immune-competent model of metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529826%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

main subject

metastatic breast cancer

1 reference

Herpes simplex virus type 1

inferred from title

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529826

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00236-3

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00236-3

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00236-3

18 March 2024

author name string

Darby L. Thomas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529826

18 March 2024

Nigel W. Fraser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529826

18 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14529826

18 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529826%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 December 2019

http://www.cell.com/article/S1525001603002363/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529826

https://api.elsevier.com/content/article/PII:S1525001603002363?httpAccept=text/xml

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00236-3

https://api.elsevier.com/content/article/PII:S1525001603002363?httpAccept=text/plain

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00236-3

18 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529826%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529826%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529826%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

543-551

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529826%20AND%20SRC:MED&resulttype=core&format=json

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

The JH2604 deletion variant of herpes simplex virus type 2 (HG52) fails to produce necrotizing encephalitis following intracranial inoculation of mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Conditionally replicating herpes vectors for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Intralesional injection of herpes simplex virus 1716 in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Requirement of an integrated immune response for successful neuroattenuated HSV-1 therapy in an intracranial metastatic melanoma model

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Genetics of natural resistance to herpesvirus infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Oncolytic viral therapy using a spontaneously generated herpes simplex virus type 1 variant for disseminated peritoneal tumor in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

The comparative pathology of human and mouse mammary glands

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Screening for recurrent breast cancer--its effectiveness and prognostic value.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900236-3

7 January 2021

Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor

17

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00236-3

Heterogeneity of tumor cells from a single mouse mammary tumor

18 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00236-3

Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model

18 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00236-3

Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant

18 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/S1525-0016(03)00236-3

18 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14529826%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference